User talk:Julianadinardo
Welcome
[edit]Hello, Julianadinardo and welcome to Wikipedia! It appears you are participating in a class project. If you haven't done so already, we encourage you to go through our training for students.
If you need help, check out Wikipedia:Questions, ask me on my talk page, or ask your question on this page and then place {{Help me}} before the question. Please also read this helpful advice for students.
Before you create an article, make sure you understand what kind of articles are accepted here. Remember: Wikipedia is an encyclopedia, and while many topics are encyclopedic, some things are not.
Your instructor or professor may wish to set up a course page, and if your class doesn't already have one please tell your instructor about that. It is highly recommended that you place this text: {{Educational assignment}} on the talk page of any articles you are working on as part of your Wikipedia-related course assignment. This will let other editors know this article is a subject of an educational assignment and aid your communication with them.
We hope you like it here and encourage you to stay even after your assignment is finished! Drm310 🍁 (talk) 14:47, 17 January 2019 (UTC)
| This user is a student editor in Northeastern_University/ENGW_30306,_Advanced_Writing_for_the_Health_Sciences_(Spring_2019) . |
Article Selection
[edit]I found an article written on prescription monitoring programs Prescription_monitoring_program
This article is very comprehensive however for each of the states, not all of the sources work to find out about each of their policies. Maybe it will be even more beneficial to provide an in-depth description of one of the states, such as Massachusetts.
Some possible references are: https://www.mass.gov/additional-pmp-information https://massachusetts.pmpaware.net/
I also found the article on NYU Langone Hospital Brooklyn NYU Langone Hospital -- Brooklyn
It is neutrally written, however is lacking very important information. Which is why I assume it was given a C grade. It discusses very important facts pertaining to their status as a hospital, and even includes some culture references. However; it neglects to mention information about the current president, notable staff, or the community in which it serves. The article should also include programs and initiatives that are apart of the hospital. Some possible references for this article are:
https://nyulangone.org/ https://health.usnews.com/best-hospitals/area/ny/nyu-langone-medical-center-6212925 http://jhubbardlab.med.nyu.edu/content/publications
Welcome!
[edit]Hello, Julianadinardo, and welcome to Wikipedia! My name is Ian and I work with the Wiki Education Foundation; I help support students who are editing as part of a class assignment.
I hope you enjoy editing here. If you haven't already done so, please check out the student training library, which introduces you to editing and Wikipedia's core principles. You may also want to check out the Teahouse, a community of Wikipedia editors dedicated to helping new users. Below are some resources to help you get started editing.
Handouts
|
|---|
Additional Resources
|
|
If you have any questions, please don't hesitate to contact me on my talk page. Ian (Wiki Ed) (talk) 15:33, 24 January 2019 (UTC)
Article Evalutation
[edit]I evaluated the article, [Monitoring Program]
Is everything in the article relevant to the article topic? Yes.
Is there anything that distracted you? The way the table was organized was very distracting. It didn't provide the information in a concise, visual way.
Is any information out of date? No, it is not out of date.
Is anything missing that could be added? In the table, there are no descriptions of each of the PMP's per state.
What else could be improved? The length and detail of the article.
Is the article neutral? Yes, it is neutral.
Are there any claims that appear heavily biased toward a particular position? No.
Are there viewpoints that are overrepresented, or underrepresented? I believe that there should be viewpoints included. This article is very factual. I think it would benefit from having arguments for and against it on the page.
Check a few citations. Do the links work? Yes
Does the source support the claims in the article? Yes
Is each fact referenced with an appropriate, reliable reference? No. There is a table that includes a list of programs by state and the sources are not linked to anything. Additionally, they are not included in the citations at the bottom.
Where does the information come from? The information is coming from medical journals.
Are these neutral sources? Yes.
If biased, is that bias noted? Not applicable.
What kinds of conversations, if any, are going on behind the scenes about how to represent this topic?
How is the article rated? Is it a part of any WikiProjects? Yes, WikiProject Medicine.
How does the way Wikipedia discusses this topic differ from the way we've talked about it in class? Not applicable.
Week 4 Exercise
[edit]The study conclude that the impact of PDMP’s is unclear, as there is only a few states that saw evidence for reduced opioid prescribing, shipments, and diversion of drug shipments, which propose a more conceptual method for evaluating PDMP’s in the future.[1]
PDMP Article Additions
[edit]History
[edit]Legislation and initiatives cannot be uniform throughout the nation. In New York designed a program called the Naloxone Co-payment Assistance Program, or N-CAP, which can help cover out-of-pocket payments when patients are picking up naloxone.[2] On a nationwide level, President Donald Trump’s administration has secured six billion dollars to stop opioid abuse. More specifically, there have also been efforts to strengthen criminal penalties for dealing and trafficking opioids.[3]
Prescription drug monitoring programs, or PDMP’s, are an example of one initiative in place to alleviate effects of the opioid crisis. The programs are designed to restrict prescription drug abuse by limiting doctor shopping, diverting controlled substances, and improving decision making.[4]
PDMP’s have been implemented in state legislations since 1939 in California, a time before researchers were aware of the highly addictive properties of opioids.[5] Since 2014, 49 states and one US territory have enacted PDMP legislation. Of the 49, 48 have utilized the programs.[6]
Missouri is the only state within the United States that doesn’t have a PDMP.[7] One reason is because their republican senator, Rob Schaaf - who is also a physician, ceased any legislation that initiated drug monitoring programs. Moreover, he has introduced his own proposal which is considered medically inept as it doesn’t require physicians to view a patient’s narcotic history. Rather, it forces doctors to send the names of patients they are considering prescribing painkillers to the health department. This would put the decision out of the doctors hands, for better or worse. On the opposition, Missouri Representative Holly Rehder and Senator Dave Schatz have proposed a more common version of the monitoring programs, one that is similar to the rest of the United States. However, both proposals have not been able to be passed through at a cost to the Missouri people.[8]
Although prescription drug monitoring programs are not new to state legislation, they are constantly being updated for the current healthcare climate. Currently, a major goal is to streamline provider access and improve provider’s understanding of PDMP reports. This is being done by integrating PDMP reports into health information technologies (HITs) such as health information exchanges (HIE), electronic health record (EHR) systems, and/ or pharmacy dispensing software (PDS) systems.[9]
A specific program that has been implemented nine states is called the PDMP Electronic Health Records Integration and Interoperability Expansion, also known as PEHRIIE. PEHRIIE activities strengthen PDMP utilization by distributing PDMP data and increasing data sharing. Moreover, increasing knowledge of separate effective practices has helped many states reach advancements.[9]
Controversy
[edit]Many doctors and researchers consider PDMP's essential in combatting the opioid epidemic. Opioid prescribing, opioid diversion and supply, opioid misuse, and opioid-related morbidity and mortality are all elements in the design of PDMP's.[5] Prescription Monitoring Programs also offer economic benefits for the states who implement them. By decreasing overall health care costs, lost productivity, and investigation times, PDMP's are effective in reducing many effects of the opioid epidemic.[6]
However, there are many studies that conclude that the impact of PDMP’s is unclear.[5] There are only a few states that saw evidence for reduced opioid prescribing, shipments, and diversion of drug shipments, which propose a more conceptual method for evaluating PDMP’s in the future. The effectiveness of these programs is up to much dispute. When examining if PDMP implementation effects changes in nonfatal and fatal events, there is no definitive evidence whether PDMP implementation increased or decreased overdoses. Furthermore, although PDMP’s have been around for a long period of time, their impact is still unknown and unperfected.
Interestingly, an increase in heroin overdoses after PDMP implementation has been commonly reported.[10] Fink et al cited that due to the small sample size and isolated nature of the study this conclusion is drawn from, the deduction could be insignificant, but does highlight the possible negative repercussions that could emerge from prescription monitoring programs.[10]
Group Peer Review
[edit]What does the article (or section) do well? This articles addresses the topic well, explaining what it is, variations by location, and future goals. This article presented the topic well given information regarding various aspects of Prescription Monitoring. Easy of the reader to understand, regardless of previous knowledge about the issue. The page is well formatted and lists where citations are needed/will be added later.
What changes would you suggest overall? Overall, the topic is well explained, however could give more details, in particular regarding future goals and aspects in which the program can change. Also, I liked chart showing the different programs in various states, but maybe explaining that in the definition (or create a section) that goes into potentially which states are doing something well or poorly, and what changes other states should be aiming to do.
What is the most important thing that the author could do to improve his/her contribution? More detail! All the details presented were well written and explained, especially with the graph, however just providing more information on the topic is the only recommendation I have :)
Did you glean anything from your classmate's work that could be applicable to your own? As if I have not already talked enough about the chart, I think this would be something I could add to my own, though I am not sure how/what I would compare! — Preceding unsigned comment added by Kyliebeck (talk • contribs) 01:17, 28 February 2019 (UTC)
Group Peer Review
[edit]What does the article (or section) do well? This article addition does a great job in providing a history to the issue as well as analyzing the controversy behind it which makes the overall article more well-rounded.
What changes would you suggest overall? I noticed you talked a lot about the situation in Missouri but I'd be interested to hear a bit more about the different programs in various states or perhaps how did the whole program start? who did it first?
What is the most important thing that the author could do to improve his/her contribution? I think just providing a bit more detail in the history portion would tie it together.
Did you glean anything from your classmate's work that could be applicable to your own? I really appreciated the section on controversy which gave the issue a well-rounded, neutral tone. I'm considering adding this to my own article. Overall great job!!
Aapro24 (talk) 05:29, 28 February 2019 (UTC)aapro24
- ^ "Evaluating the impact of prescription drug monitoring program implementation: a scoping review".
{{cite journal}}: Cite journal requires|journal=(help) - ^ Addressing the Opioid Epidemic in New...)[full citation needed]
- ^ President Donald J. Trump's Initiative to Stop Opioid Abuse and Reduce Drug Supply and Demand. (n.d.). Retrieved from https://www.whitehouse.gov/briefings-statements/president-donald-j-trumps-initiative-stop-opioid-abuse-reduce-drug-supply-demand-2/
- ^ Department of Health. (n.d.). Retrieved from https://www.health.ny.gov/community/opioid_epidemic
- ^ a b c Finley, Erin P.; Garcia, Ashley; Rosen, Kristen; McGeary, Don; Pugh, Mary Jo; Potter, Jennifer Sharpe (20 June 2017). "Evaluating the impact of prescription drug monitoring program implementation: a scoping review". BMC Health Services Research. 17 (1). doi:10.1186/s12913-017-2354-5. PMC 5477729. PMID 28633638.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ a b Briefing on PDMP Effectiveness. (2014). In Prescription Drug Monitoring Program Center of Excellence At Brandeis (p. 13). Brandeis University .
- ^ Thielking, M., Ross, C., Branswell, H., Hogan, A., & Associated Press. (2017, March 7). Missouri is the only state not tracking prescription drug use. Here’s why. Retrieved January 24, 2019, from https://www.statnews.com/2017/03/07/missouri-prescription-drug-database/
- ^ Lange, J; Gaddis, G; Varner, E; Schmidt, S; Cohen, R; Schwarz, E (2018). "Resident Access to the St. Louis County Prescription Drug Monitoring Program: Why PDMPs Matter and How to Gain Access". Missouri medicine. 115 (6): 487–493. PMID 30643325.
- ^ a b "Integrating & Expanding Prescription Drug Monitoring Program Data: Lessons from Nine States" (PDF). National Center for Injury Prevention and Control. February 2017.
- ^ a b Fink, David S.; Schleimer, Julia P.; Sarvet, Aaron; Grover, Kiran K.; Delcher, Chris; Castillo-Carniglia, Alvaro; Kim, June H.; Rivera-Aguirre, Ariadne E.; Henry, Stephen G.; Martins, Silvia S.; Cerdá, Magdalena (8 May 2018). "Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses". Annals of Internal Medicine. 168 (11): 783. doi:10.7326/M17-3074. PMC 6015770. PMID 29801093.